SCHEMBL21167392

SCHEMBL21167392

FC(F)(F)Cn1cc(-c2cnc3c(n2)N(Cc2ccc4nccn4n2)NN3)cn1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MET P08581 5/20 0.46
LRRK2 Q5S007 1/20 0.32
PIM1 P11309 6/20 0.32
PIM3 Q86V86 5/20 0.31
PIM2 Q9P1W9 5/20 0.31
JAK2 O60674 1/20 0.30
RET P07949 1/20 0.30
KDR P35968 1/20 0.30
GSK3A P49840 1/20 0.30
RPS6KA3 P51812 1/20 0.30
LIMK1 P53667 1/20 0.30
MAP2K1 Q02750 1/20 0.30
DYRK1A Q13627 1/20 0.30
MAPK14 Q16539 1/20 0.30
CLK4 Q9HAZ1 1/20 0.30
ALK Q9UM73 1/20 0.30
DYRK1B Q9Y463 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167685 0.88 MET (0.48) METJAK2KDR
SCHEMBL16882499 0.83 MET (0.64) METLRRK2PIM1PIM3PIM2
SCHEMBL23128008 0.81 MET (0.46) METLRRK2PIM1PIM3PIM2
SCHEMBL17425926 0.79 MET (0.49) METLRRK2PIM1PIM3PIM2
SCHEMBL12487546 0.78 MET (0.73) MET
SCHEMBL17425942 0.77 MET (0.43) METPIM1JAK2DYRK1A
SCHEMBL21167393 0.74 MET (0.44) METPIM1PIM3PIM2JAK2
SCHEMBL24591003 0.72 MET (0.42) METJAK2RETKDRGSK3A
SCHEMBL17425918 0.71 MET (0.59) METLRRK2PIM1PIM3PIM2
SCHEMBL24591016 0.71 MET (0.47) METJAK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2021-03-24 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed